Trials / Completed
CompletedNCT01899430
Polycystic Ovary Syndrome and Liraglutide
Short-term Liraglutide Treatment in Obese Women With Polycystic Ovary Syndrome
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- University Medical Centre Ljubljana · Academic / Other
- Sex
- Female
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to determine whether liraglutide is more effective than metformin in the treatment of obese women with newly diagnosed polycystic ovary syndrome (PCOS). We anticipated greater changes in body weight in patients treated with liraglutide than in those treated with metformin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | liraglutide | |
| DRUG | metformin |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2012-10-01
- Completion
- 2013-04-01
- First posted
- 2013-07-15
- Last updated
- 2013-07-15
Locations
1 site across 1 country: Slovenia
Source: ClinicalTrials.gov record NCT01899430. Inclusion in this directory is not an endorsement.